28,838 Shares in iShares Biotechnology ETF $IBB Bought by CMH Wealth Management LLC

CMH Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 28,838 shares of the financial services provider’s stock, valued at approximately $5,485,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in IBB. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at about $201,000. AQR Capital Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $455,000. Millennium Management LLC increased its stake in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. M&T Bank Corp increased its stake in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares in the last quarter. Finally, Walleye Capital LLC raised its holdings in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after buying an additional 985 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $209.05 on Tuesday. iShares Biotechnology ETF has a 52 week low of $137.63 and a 52 week high of $217.12. The company’s 50 day moving average price is $195.65 and its two-hundred day moving average price is $179.17.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.0%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.